OLB-AC: Towards Optimizing Ligand Bioactivities Through Deep Graph Learning and Activity Cliffs.

Researchers

Journal

Modalities

Models

Abstract

Deep graph learning (DGL) has been widely employed in the realm of ligand-based virtual screening (LBVS). Within this field, a key hurdle is the existence of activity cliffs (ACs), where minor chemical alterations can lead to significant changes in bioactivity. In response, several DGL models have been developed to enhance ligand bioactivity prediction in the presence of ACs. Yet, there remains a largely unexplored opportunity within ACs for optimizing ligand bioactivity, making it an area ripe for further investigation.We present a novel approach to simultaneously predict and optimize ligand bioactivities through deep graph learning and activity cliffs (OLB-AC). OLB-AC possesses the capability to optimize ligand molecules located near ACs, providing a direct reference for optimizing ligand bioactivities with the matching of original ligands. To accomplish this, a novel attentive graph reconstruction neural network (AGRN) and ligand optimization scheme are proposed. AGRN reconstructs original ligands and optimizes them through adversarial representations derived from their bioactivity prediction process. Experimental results on 9 drug targets reveal that out of the 667 molecules generated through OLB-AC optimization on datasets comprising 974 low-activity, non-inhibitor, or highly toxic ligands, 49 are recognized as known highly active, inhibitor, or non-toxic ligands beyond the datasets’ scope. The 27 out of 49 matched molecular pairs generated by OLB-AC reveal novel transformations not present in their training sets. The adversarial representations employed for ligand optimization originate from the gradients of bioactivity predictions. Therefore, we also assess OLB-AC’s prediction accuracy across 33 different bioactivity datasets. Results show that OLB-AC achieves the best Pearson correlation coefficient (r2) on 27/33 datasets, with an average improvement of 7.2 ∼ 22.9% against the state-of-the-art bioactivity prediction methods.The code and dataset developed in this work are available at github.com/Yueming-Yin/OLB-AC.© The Author(s) 2024. Published by Oxford University Press.